We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Investors Should Add Aflac Stock to Their Portfolio Now
Read MoreHide Full Article
Aflac Incorporated (AFL - Free Report) is well-poised to grow on the back of a strong U.S. business, product launches and upgrades coupled with expanding cash reserves.
AFL’s Zacks Rank & Price Performance
AFL currently carries a Zacks Rank #2 (Buy).
The stock has gained 30.1% in the past six months compared with the industry’s 33.1% growth. The Finance sector and the S&P 500 Composite have risen 10.1% and 14.2%, respectively, in the same time frame.
Image Source: Zacks Investment Research
Trend in Estimates
The Zacks Consensus Estimate for AFL’s 2024 earnings is pegged at $7.27 per share, indicating growth of 16.7% from the prior-year figure. The consensus mark for 2025 earnings is pegged at $7.21 per share. The Zacks Consensus Estimate for 2024 earnings has been revised 6.4% upward in the past 30 days.
Key Drivers
Aflac's revenues are bolstered by strong sales in its U.S. and Japan segments, driven by strategic growth investments, robust persistency rates and enhanced productivity. The company designs and markets supplemental insurance products across both countries through its Japan and U.S. segments. Increased sales of these products are likely to boost its premiums in the days ahead, which are a key contributor to an insurer’s revenue growth.
Aflac introduces new products and upgrades existing ones to address its customers' changing needs. In July 2024, it partnered with SKYGEN to enhance dental and vision benefits management, leveraging advanced technology and streamlined processes to boost customer satisfaction and product sales. AFL’s Japan unit launched Tsumitasu, which targets young and middle-aged customers. This launch drove the 12.3% increase in third-quarter sales. Upcoming cancer insurance product for spring 2025 should further support this metric.
The company also integrates digital solutions into its offerings to align with the ongoing trend of digitization. Aflac’s significant investments in digital transformation have improved operational efficiencies and facilitated a shift to digital sales channels, which could continue to support strong profit margins in the days ahead. The expense ratio in the U.S. improved 260 basis points year over year in the third quarter.
Aflac’s solid financial position, supported by a strong cash balance and substantial cash flow, is a key strength. As of Sept. 30, 2024, cash and cash equivalents surged 30.2% from the 2023-end level. In the nine months of 2024, Aflac generated $2.4 billion in operating cash flows. This financial stability enables the company to pursue growth initiatives and engage in prudent capital deployment through share repurchases and dividend payments.
Kemper’s earnings surpassed the Zacks Consensus Estimate in two of the last four quarters, met once and missed the other time, with an average surprise of 10.5%. The Zacks Consensus Estimate for KMPR’s 2024 earnings indicates an 824.3% year-over-year rise. Its revenues for 2024 are projected to be $4.6 billion. The consensus mark for KMPR’s earnings has moved 6.8% north in the past 30 days.
CNO Financial’s earnings surpassed estimates in three of the last four quarters and missed once, with an average surprise of 24.5%. The Zacks Consensus Estimate for CNO’s 2024 earnings indicates a 20.7% year-over-year rise. Its revenues are projected to be $3.7 billion in 2024. The consensus mark for CNO’s 2024 earnings has moved 8.7% north in the past 30 days.
Primerica’s earnings outpaced estimates in two of the trailing four quarters and missed twice, the average surprise being 4.9%. The Zacks Consensus Estimate for PRI’s 2024 earnings is pegged at $19.32 per share. Meanwhile, revenues are projected to be $3 billion for 2024. The consensus mark for PRI’s 2024 earnings has moved up 1% in the past 30 days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why Investors Should Add Aflac Stock to Their Portfolio Now
Aflac Incorporated (AFL - Free Report) is well-poised to grow on the back of a strong U.S. business, product launches and upgrades coupled with expanding cash reserves.
AFL’s Zacks Rank & Price Performance
AFL currently carries a Zacks Rank #2 (Buy).
The stock has gained 30.1% in the past six months compared with the industry’s 33.1% growth. The Finance sector and the S&P 500 Composite have risen 10.1% and 14.2%, respectively, in the same time frame.
Image Source: Zacks Investment Research
Trend in Estimates
The Zacks Consensus Estimate for AFL’s 2024 earnings is pegged at $7.27 per share, indicating growth of 16.7% from the prior-year figure. The consensus mark for 2025 earnings is pegged at $7.21 per share. The Zacks Consensus Estimate for 2024 earnings has been revised 6.4% upward in the past 30 days.
Key Drivers
Aflac's revenues are bolstered by strong sales in its U.S. and Japan segments, driven by strategic growth investments, robust persistency rates and enhanced productivity. The company designs and markets supplemental insurance products across both countries through its Japan and U.S. segments. Increased sales of these products are likely to boost its premiums in the days ahead, which are a key contributor to an insurer’s revenue growth.
Aflac introduces new products and upgrades existing ones to address its customers' changing needs. In July 2024, it partnered with SKYGEN to enhance dental and vision benefits management, leveraging advanced technology and streamlined processes to boost customer satisfaction and product sales. AFL’s Japan unit launched Tsumitasu, which targets young and middle-aged customers. This launch drove the 12.3% increase in third-quarter sales. Upcoming cancer insurance product for spring 2025 should further support this metric.
The company also integrates digital solutions into its offerings to align with the ongoing trend of digitization. Aflac’s significant investments in digital transformation have improved operational efficiencies and facilitated a shift to digital sales channels, which could continue to support strong profit margins in the days ahead. The expense ratio in the U.S. improved 260 basis points year over year in the third quarter.
Aflac’s solid financial position, supported by a strong cash balance and substantial cash flow, is a key strength. As of Sept. 30, 2024, cash and cash equivalents surged 30.2% from the 2023-end level. In the nine months of 2024, Aflac generated $2.4 billion in operating cash flows. This financial stability enables the company to pursue growth initiatives and engage in prudent capital deployment through share repurchases and dividend payments.
Other Stocks to Consider
Some other top-ranked stocks in the insurance space are Kemper Corporation (KMPR - Free Report) , CNO Financial Group, Inc. (CNO - Free Report) and Primerica, Inc. (PRI - Free Report) . Each stock presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Kemper’s earnings surpassed the Zacks Consensus Estimate in two of the last four quarters, met once and missed the other time, with an average surprise of 10.5%. The Zacks Consensus Estimate for KMPR’s 2024 earnings indicates an 824.3% year-over-year rise. Its revenues for 2024 are projected to be $4.6 billion. The consensus mark for KMPR’s earnings has moved 6.8% north in the past 30 days.
CNO Financial’s earnings surpassed estimates in three of the last four quarters and missed once, with an average surprise of 24.5%. The Zacks Consensus Estimate for CNO’s 2024 earnings indicates a 20.7% year-over-year rise. Its revenues are projected to be $3.7 billion in 2024. The consensus mark for CNO’s 2024 earnings has moved 8.7% north in the past 30 days.
Primerica’s earnings outpaced estimates in two of the trailing four quarters and missed twice, the average surprise being 4.9%. The Zacks Consensus Estimate for PRI’s 2024 earnings is pegged at $19.32 per share. Meanwhile, revenues are projected to be $3 billion for 2024. The consensus mark for PRI’s 2024 earnings has moved up 1% in the past 30 days.